Order Brochure

  

Mon, Jan 25, 2010 * PROTEONOMIX, INC. Files SEC form 8-K, Other Events EDGAR Online (Mon, Jan 25)

*Proteonomix, Inc. (PROT) Responds to Recent Internet Articles Relating to Its Subsidiary, Proteoderm, Inc. Marketwire (Mon, Jan 25)

Wed, Dec 30, 2009 * PROTEONOMIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online (Wed, Dec 30) Tue, Dec 29, 2009

* Proteonomix, Inc. (PROT) Announces Change in Officers/Directors Marketwire (Tue, Dec 29)

Proteonomix has filed a registration statement on Form 10 with the Securities and Exchange Commission.
Filings may be found at the following link:
http://www.sec.gov/cgi-bin/browse-edgar?company=Proteonomix&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Proteonomix trades under the symbol PROT.PK

02.10.09: Proteonomix, Inc. (PROT) Announces Definitive Agreement for Sale of Its Stem Cell Derived Cosmeceutical Products With Two Companies Headquartered in China

01.15.09: International Business Times announces Proteonomix, Inc.(PROT) is "One to Watch"

01.05.09:Proteonomix, Inc.(PROT) announces the appointment of Steven Byle to its Board of Directors effective January 15, 2009.

12.15.08: Proteonomix, Inc. Announces the Publication of Research on Use of Umbilical Cord Blood in Growing Undifferentiated Embryonic Stem Cells

12.08.08:Proteonomix, Inc. Announces That Its Subsidiary, Proteoderm, Inc., Has Entered Into a Letter of Intent With Sinoquest Investment Limited for the Licensing, Purchase and Distribution of Proteoderm's Co.


 
© Copyright 2010 PROTEONOMIX , Inc.
Home | Who We Are | What We Do | Proteonomix Cord Blood Bank | Product Development | Practitioners |
Investor Information | Partners | Media Inquiries | News & Events | Careers | Contact | Site Map